These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Glipizide ('Glibenese') in maturity-onset diabetes mellitus. Klaassen CH Curr Med Res Opin; 1979; 6(1):8-13. PubMed ID: 378559 [TBL] [Abstract][Full Text] [Related]
5. A clinical trial with glipizide - a relative new sulphonylurea. Singarayar J; Sunderam S Med J Zambia; 1978; 12(4):97. PubMed ID: 398642 [TBL] [Abstract][Full Text] [Related]
6. Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus. Aman M; Jawad F; Sultana S; Waiz-ul-Haq ; Nanji R J Pak Med Assoc; 1977 Mar; 27(3):293-5. PubMed ID: 409862 [TBL] [Abstract][Full Text] [Related]
7. Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide. Lecomte MJ; Luyckx AS; Lefebvre PJ Diabete Metab; 1977 Dec; 3(4):239-43. PubMed ID: 340296 [No Abstract] [Full Text] [Related]
8. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)]. Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of glipizide. Melander A; Wåhlin-Boll E Am J Med; 1983 Nov; 75(5B):41-5. PubMed ID: 6424440 [TBL] [Abstract][Full Text] [Related]
10. Influence of sulfonylureas on the secretion, disposal and effect of insulin. Almér LO; Johansson E; Melander A; Wåhlin-Boll E Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169 [TBL] [Abstract][Full Text] [Related]
11. [Duration of effective hypoglycaemic action of glipizide given once daily (author's transl)]. Azzopardi J; Campbell IW; Clarke BF; Duncan LJ Med Klin; 1975 Jul; 70(28-29):1214-8. PubMed ID: 809650 [TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024). Bandisode MS; Boshell BR Horm Metab Res; 1976 Mar; 8(2):89-91. PubMed ID: 770300 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept]. Selam JL Diabetes Metab; 1997 Nov; 23 Suppl 4():39-43. PubMed ID: 9463023 [TBL] [Abstract][Full Text] [Related]
14. [Kinetic aspects of the glipizide-induced hypoglycemia in the dog (author's transl)]. Blayac JP; Ribes G; Valette JF; Loubatières-Mariani MM J Pharmacol; 1980; 11(4):463-72. PubMed ID: 7206734 [TBL] [Abstract][Full Text] [Related]
15. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics. Groop L; Harno K Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763 [TBL] [Abstract][Full Text] [Related]
16. Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use. Lebovitz HE Pharmacotherapy; 1985; 5(2):63-77. PubMed ID: 3923454 [TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of glipizide. Results of a multicentric study in Spain]. Cerdeño VM; Passigli AG; Calvet J; Soler J Rev Iber Endocrinol; 1975; 22(127):43-60. PubMed ID: 1145006 [TBL] [Abstract][Full Text] [Related]
18. Oral sulfonylureas for the treatment of type II diabetes: an update. Shank WA; Morrison AD South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015 [TBL] [Abstract][Full Text] [Related]
19. Glyburide and glipizide. Med Lett Drugs Ther; 1984 Aug; 26(669):79-80. PubMed ID: 6433158 [No Abstract] [Full Text] [Related]
20. Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers. Sartor G; Melander A; Scherstén B; Wåhlin-Boll E Acta Med Scand; 1980; 208(4):301-7. PubMed ID: 6778079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]